Art Unit 1618
Group 1610Pharmaceutical and Agricultural Compositions
- Active examiners
- 20
- Average office actions per grant
- 2.53
Grant ratio
- Art Unit 1618
- 44.8%
- Group 1610
- 43.3%
Active examiners
| Paul Dickinson | 58.7% | 2.35 | August 2026 |
|---|---|---|---|
| Micah-Paul Young | 50.9% | 2.59 | August 2026 |
| D. L. Jones | 58.1% | 2.19 | August 2026 |
| Nissa Westerberg | 21.6% | 3.10 | August 2026 |
| James W Rogers | 42.6% | 2.65 | August 2026 |
| Melissa Perreira | 48.4% | 2.58 | August 2026 |
| Jake Vu | 36.6% | 2.79 | August 2026 |
| Jagadishwar Rao Samala | 64.1% | 1.88 | August 2026 |
| Robert S Cabral | 61.2% | 2.86 | August 2026 |
| Sean R Donohue | 36.8% | 2.76 | August 2026 |
| Leah H Schlientz | 37.2% | 2.61 | August 2026 |
| Blessing M. Fubara | 24.6% | 2.12 | August 2026 |
| Kaila A Craig | 14.9% | 2.00 | August 2026 |
| Shirley V. Gembeh | 21.1% | 1.90 | August 2026 |
| Samantha L. Mejias | 5.2% | 1.60 | August 2026 |
| Eric E. Silverman | 32.9% | 2.17 | July 2026 |
| Jong Hwan Baek | 0.0% | N/A | August 2026 |
| Susan Tran | 57.1% | 2.41 | August 2026 |
| Liliana Cerullo | 0.0% | 1.00 | July 2026 |
| James David Burgess | 0.0% | N/A | August 2026 |
Examiner distribution
- Median grant ratio
- 36.8%
- Middle 50% of grant ratios
- 21.6%–50.9%
- Median office actions / grant
- 2.46
- Middle 50% of office actions / grant
- 2.09–2.68
Active examiners with at least 20 applications.
Other associated examiners
Examiners without recent activity.
| Lance Rider | 30.8% | 2.59 | March 2024 Appears inactive |
|---|---|---|---|
| Jennifer Lamberski | 51.7% | 2.99 | August 2025 Appears inactive |
| Nabila Ebrahim | 34.6% | 2.88 | December 2020 Appears inactive |
| Eric E. Silverman | 38.1% | 2.21 | January 2010 Appears inactive |
| Sun Y. Kim | 48.6% | 1.67 | March 2014 Appears inactive |
| Humera N. Sheikh | 77.8% | 2.31 | March 2026 Potentially inactive |
| Hasan Ahmed | 0.0% | 2.64 | November 2022 Appears inactive |
| Maksymilian A Nowak | 0.0% | N/A | October 2024 Appears inactive |
Based on available public USPTO records; may be incomplete.